Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2025-12-28 @ 2:33 AM
Study NCT ID:
NCT02632435
Status:
COMPLETED
Last Update Posted:
2019-09-06
First Post:
2015-12-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment.
Sponsor:
Ottawa Hospital Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04
Start Date Type:
None
Primary Completion Date:
2019-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-08
First Submit QC Date:
None
Study First Post Date:
2015-12-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-03
Last Update Post Date:
2019-09-06
Last Update Post Date Type:
ACTUAL